News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
675,471 Results
Type
Article (60286)
Company Profile (134)
Press Release (615051)
Section
Business (186125)
Career Advice (2775)
Deals (34336)
Drug Delivery (94)
Drug Development (78874)
Employer Resources (157)
FDA (16161)
Job Trends (14810)
News (325054)
Policy (32158)
Tag
Academia (2731)
Alliances (46119)
Alzheimer's disease (1223)
Approvals (16117)
Artificial intelligence (154)
Bankruptcy (317)
Best Places to Work (11331)
Breast cancer (188)
Cancer (1362)
Cardiovascular disease (109)
Career advice (2348)
CAR-T (100)
Cell therapy (289)
Clinical research (63245)
Collaboration (481)
Compensation (184)
COVID-19 (2532)
C-suite (122)
Data (1390)
Diabetes (173)
Diagnostics (6149)
Earnings (66253)
Employer resources (139)
Events (100329)
Executive appointments (413)
FDA (16871)
Funding (425)
Gene therapy (191)
GLP-1 (609)
Government (4623)
Healthcare (19056)
Infectious disease (2622)
Inflammatory bowel disease (116)
Interviews (526)
IPO (15486)
Job creations (3867)
Job search strategy (1982)
Layoffs (457)
Legal (7346)
Lung cancer (201)
Manufacturing (194)
Medical device (14090)
Medtech (14095)
Mergers & acquisitions (19042)
Metabolic disorders (456)
Neuroscience (1544)
NextGen Class of 2024 (6716)
Non-profit (4499)
Northern California (1587)
Obesity (260)
Opinion (216)
Parkinson's disease (97)
Patents (119)
People (59699)
Phase I (19620)
Phase II (27738)
Phase III (20725)
Pipeline (491)
Postmarket research (2630)
Preclinical (8198)
Radiopharmaceuticals (246)
Rare diseases (258)
Real estate (6231)
Regulatory (21671)
Research institute (2405)
Resumes & cover letters (414)
Southern California (1387)
Startups (3588)
United States (14505)
Vaccines (576)
Weight loss (188)
Date
Today (2)
Last 7 days (237)
Last 30 days (2125)
Last 365 days (33798)
2024 (33735)
2023 (38215)
2022 (49102)
2021 (53984)
2020 (53180)
2019 (47182)
2018 (35852)
2017 (32439)
2016 (32068)
2015 (37493)
2014 (30633)
2013 (26912)
2012 (28481)
2011 (28659)
2010 (27365)
Location
Africa (889)
Arizona (164)
Asia (40085)
Australia (7009)
California (3556)
Canada (1399)
China (306)
Colorado (172)
Connecticut (174)
Europe (91139)
Florida (518)
Georgia (136)
Illinois (421)
Indiana (214)
Maryland (642)
Massachusetts (2657)
Michigan (178)
Minnesota (297)
New Jersey (1072)
New York (1017)
North Carolina (775)
Northern California (1587)
Ohio (146)
Pennsylvania (881)
South America (1236)
Southern California (1387)
Texas (543)
Utah (110)
Washington State (374)
675,471 Results for "medical college of georgia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ChromaCode Announces Partnership with Department of Pathology, Medical College of Georgia on rapid testing for critical biomarkers in Non-Small Cell Lung Cancer
ChromaCode, Inc. today announced a partnership with Department of Pathology, Medical College of Georgia , to test the analytical and clinical performance of ChromaCode’s HDPCR non-small cell lung cancer.
March 20, 2024
·
3 min read
Business
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, completed the expansion of its global manufacturing and distribution facilities in Roswell, Georgia.
June 4, 2024
·
6 min read
Press Releases
Improving the Math Behind Stroke Rehabilitation First-of-its-Kind Assistive Robot Enhances Traditional Stroke Recovery by Making Daily Exercises Fun and Engaging
Georgia State researchers are readying the technology for large-scale use by applying advanced math to refine the devices’ ability to autonomously classify range of motion
December 6, 2024
·
1 min read
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American College of Cardiology (ACC.24) at the Georgia World Congress Center in Atlanta, GA, April 6 – 8, 2024.
April 1, 2024
·
3 min read
Thryv Therapeutics to Present Results of Wave I Part 1 Clinical Study at American College of Cardiology Conference in Atlanta, Georgia on April 7th, 2024
Thryv Therapeutics is pleased to announce the presentation of its poster: SGK1 inhibitor LQT-1213 significantly attenuates dofetilide-induced QT prolongation in humans: Results of the WAVE I Clinical Study at the American College of Cardiology Conference.
March 26, 2024
·
3 min read
Biotech Beach
Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting
Ionis Pharmaceuticals, Inc. announced today that it will present positive Phase 3 Balance results in patients with familial chylomicronemia syndrome (FCS) for the company’s lead independent, investigational medicine, olezarsen, at the 2024 American College of Cardiology (ACC) Annual Meeting in Atlanta, Georgia.
March 25, 2024
·
6 min read
BioMidwest
LIB Therapeutics Announces Abstracts Accepted for Presentation at the American College of Cardiology Scientific Session 2024
LIB Therapeutics Inc. (LIB) today announced acceptance of two abstracts from the recently completed Phase 3 registration-enabling LIBerate program for presentation at the American College of Cardiology 2024 in Atlanta, Georgia on April 6-8, 2024.
February 13, 2024
·
2 min read
Drug Development
LIB Therapeutics Announces Positive Results from LIBerate-HR Study: A 52-Week, Placebo-Controlled Registration-Enabling Trial of Lerodalcibep at Late-Breaking Session at American College of Cardiology 2024
LIB Therapeutics Inc. announced positive results from two studies in the recently completed Phase 3 LIBerate registration-enabling program were presented at the American College of Cardiology 2024 in Atlanta, Georgia on April 6-8, 2024.
April 8, 2024
·
5 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
·
5 min read
NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”) today announced that it will present additional data from the Phase 2 ROSE2 clinical trial at the 2024 American College of Cardiology Congress (“ACC”) in Atlanta, Georgia, being held April 6-8.
March 25, 2024
·
7 min read
1 of 67,548
Next
